| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor binding | 1.52e-04 | 34 | 61 | 3 | GO:0050750 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor binding | 2.29e-04 | 39 | 61 | 3 | GO:0070325 | |
| GeneOntologyBiologicalProcess | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 7.91e-06 | 14 | 59 | 3 | GO:0060213 | |
| GeneOntologyBiologicalProcess | regulation of nuclear-transcribed mRNA poly(A) tail shortening | 1.21e-05 | 16 | 59 | 3 | GO:0060211 | |
| GeneOntologyBiologicalProcess | positive regulation of receptor-mediated endocytosis | 4.05e-05 | 67 | 59 | 4 | GO:0048260 | |
| GeneOntologyBiologicalProcess | collateral sprouting in absence of injury | 8.00e-05 | 5 | 59 | 2 | GO:0048669 | |
| GeneOntologyBiologicalProcess | regulation of receptor-mediated endocytosis | 8.36e-05 | 156 | 59 | 5 | GO:0048259 | |
| GeneOntologyBiologicalProcess | nuclear-transcribed mRNA poly(A) tail shortening | 1.14e-04 | 33 | 59 | 3 | GO:0000289 | |
| GeneOntologyBiologicalProcess | positive regulation of receptor internalization | 1.25e-04 | 34 | 59 | 3 | GO:0002092 | |
| GeneOntologyCellularComponent | clathrin-coated pit | 3.08e-06 | 80 | 59 | 5 | GO:0005905 | |
| GeneOntologyCellularComponent | endosome to plasma membrane transport vesicle | 2.35e-05 | 3 | 59 | 2 | GO:0070381 | |
| GeneOntologyCellularComponent | P-body | 1.98e-04 | 102 | 59 | 4 | GO:0000932 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 3.40e-04 | 332 | 59 | 6 | GO:0005788 | |
| Domain | Ago_hook | 3.31e-08 | 3 | 61 | 3 | PF10427 | |
| Domain | TNRC6_PABC-bd | 3.31e-08 | 3 | 61 | 3 | IPR032226 | |
| Domain | Argonaute_hook_dom | 3.31e-08 | 3 | 61 | 3 | IPR019486 | |
| Domain | TNRC6-PABC_bdg | 3.31e-08 | 3 | 61 | 3 | PF16608 | |
| Domain | M_domain | 1.05e-05 | 2 | 61 | 2 | PF12938 | |
| Domain | GW182_M_dom | 1.05e-05 | 2 | 61 | 2 | IPR026805 | |
| Domain | BAT2_N | 3.14e-05 | 3 | 61 | 2 | PF07001 | |
| Domain | BAT2_N | 3.14e-05 | 3 | 61 | 2 | IPR009738 | |
| Domain | PRRC2 | 3.14e-05 | 3 | 61 | 2 | IPR033184 | |
| Domain | UBA-like | 1.20e-03 | 64 | 61 | 3 | IPR009060 | |
| Domain | Cupredoxin | 2.32e-03 | 22 | 61 | 2 | IPR008972 | |
| Domain | JmjC | 2.77e-03 | 24 | 61 | 2 | PF02373 | |
| Domain | - | 3.24e-03 | 26 | 61 | 2 | 1.25.40.90 | |
| Domain | ENTH_VHS | 4.02e-03 | 29 | 61 | 2 | IPR008942 | |
| Domain | TIG | 4.59e-03 | 31 | 61 | 2 | PF01833 | |
| Domain | Ig_E-set | 4.78e-03 | 104 | 61 | 3 | IPR014756 | |
| Domain | JMJC | 4.89e-03 | 32 | 61 | 2 | PS51184 | |
| Domain | IPT | 4.89e-03 | 32 | 61 | 2 | IPR002909 | |
| Domain | JmjC_dom | 4.89e-03 | 32 | 61 | 2 | IPR003347 | |
| Domain | JmjC | 5.19e-03 | 33 | 61 | 2 | SM00558 | |
| Pathway | REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS | 7.93e-07 | 7 | 41 | 3 | M46421 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_MRNA_TRANSLATION | 1.90e-06 | 9 | 41 | 3 | M27810 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_MRNA_TRANSLATION | 1.90e-06 | 9 | 41 | 3 | M46436 | |
| Pathway | REACTOME_REGULATION_OF_CDH11_MRNA_TRANSLATION_BY_MICRORNAS | 2.70e-06 | 10 | 41 | 3 | M48013 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_GENE_EXPRESSION | 6.40e-06 | 13 | 41 | 3 | M46434 | |
| Pathway | REACTOME_REGULATION_OF_RUNX1_EXPRESSION_AND_ACTIVITY | 1.51e-05 | 17 | 41 | 3 | M27788 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_APOPTOSIS | 2.14e-05 | 19 | 41 | 3 | M48238 | |
| Pathway | REACTOME_PTEN_REGULATION | 4.89e-05 | 139 | 41 | 5 | M27646 | |
| Pathway | REACTOME_TGFBR3_EXPRESSION | 7.11e-05 | 28 | 41 | 3 | M48253 | |
| Pathway | REACTOME_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION | 1.07e-04 | 32 | 41 | 3 | M48012 | |
| Pathway | REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY | 1.07e-04 | 32 | 41 | 3 | M27900 | |
| Pathway | REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS | 1.23e-04 | 6 | 41 | 2 | MM15083 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_NPAS4 | 1.28e-04 | 34 | 41 | 3 | M46422 | |
| Pathway | REACTOME_ONCOGENE_INDUCED_SENESCENCE | 1.40e-04 | 35 | 41 | 3 | M27190 | |
| Pathway | REACTOME_MAPK6_MAPK4_SIGNALING | 1.49e-04 | 93 | 41 | 4 | M27572 | |
| Pathway | REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX | 1.66e-04 | 37 | 41 | 3 | M29790 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_VENTX | 2.25e-04 | 41 | 41 | 3 | M29748 | |
| Pathway | REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS | 2.67e-04 | 313 | 41 | 6 | M27867 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 3.39e-04 | 47 | 41 | 3 | M29777 | |
| Pathway | REACTOME_SIGNALING_BY_TGFBR3 | 3.83e-04 | 49 | 41 | 3 | M48250 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | 3.96e-04 | 120 | 41 | 4 | MM14982 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | 4.49e-04 | 124 | 41 | 4 | M27285 | |
| Pathway | REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2 | 5.37e-04 | 130 | 41 | 4 | MM15455 | |
| Pathway | REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2 | 5.69e-04 | 132 | 41 | 4 | M724 | |
| Pathway | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | 6.31e-04 | 58 | 41 | 3 | M11980 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 6.97e-04 | 246 | 41 | 5 | M10189 | |
| Pathway | REACTOME_CA2_PATHWAY | 7.67e-04 | 62 | 41 | 3 | M27321 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2 | 8.03e-04 | 63 | 41 | 3 | M27862 | |
| Pathway | REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING | 8.30e-04 | 146 | 41 | 4 | M27288 | |
| Pathway | REACTOME_HEMOSTASIS | 1.17e-03 | 571 | 41 | 7 | MM14472 | |
| Pathway | REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS | 1.52e-03 | 20 | 41 | 2 | M497 | |
| Pathway | REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS | 1.52e-03 | 20 | 41 | 2 | MM15469 | |
| Pathway | REACTOME_TP53_REGULATES_METABOLIC_GENES | 1.85e-03 | 84 | 41 | 3 | M27495 | |
| Pathway | REACTOME_CELL_CELL_JUNCTION_ORGANIZATION | 2.25e-03 | 90 | 41 | 3 | M820 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | 2.26e-03 | 1022 | 41 | 9 | MM15436 | |
| Pathway | KEGG_MEDICUS_VARIANT_MLL_AF4_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION | 2.57e-03 | 26 | 41 | 2 | M47439 | |
| Pathway | REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION | 2.63e-03 | 95 | 41 | 3 | M48268 | |
| Pathway | REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION | 2.70e-03 | 96 | 41 | 3 | M27792 | |
| Pathway | REACTOME_HEMOSTASIS | 3.13e-03 | 679 | 41 | 7 | M8395 | |
| Pathway | WP_KLEEFSTRA_SYNDROME | 3.19e-03 | 29 | 41 | 2 | M48076 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA | 3.19e-03 | 29 | 41 | 2 | M783 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA | 3.19e-03 | 29 | 41 | 2 | MM15444 | |
| Pathway | REACTOME_CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS | 3.21e-03 | 102 | 41 | 3 | MM15498 | |
| Pubmed | Impact of scaffolding protein TNRC6 paralogs on gene expression and splicing. | 5.39e-09 | 3 | 62 | 3 | 34108231 | |
| Pubmed | 5.39e-09 | 3 | 62 | 3 | 16880270 | ||
| Pubmed | 5.39e-09 | 3 | 62 | 3 | 31670606 | ||
| Pubmed | Two PABPC1-binding sites in GW182 proteins promote miRNA-mediated gene silencing. | 2.16e-08 | 4 | 62 | 3 | 21063388 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 3.98e-08 | 184 | 62 | 7 | 32908313 | |
| Pubmed | PCF11 ASXL1 WDR33 SVIL TNRC6A TNRC6B CEP152 TNRC6C TRIM24 KDM6A PRRC2A JMJD1C YTHDF2 PRRC2B | 1.68e-07 | 1429 | 62 | 14 | 35140242 | |
| Pubmed | Functional dissection of the human TNRC6 (GW182-related) family of proteins. | 1.88e-07 | 7 | 62 | 3 | 19470757 | |
| Pubmed | 1.88e-07 | 7 | 62 | 3 | 19383768 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | PLEKHG1 C2CD3 CALD1 SVIL TNRC6A TNRC6B COBL CEP152 TNRC6C YTHDF2 PRRC2B | 2.95e-07 | 853 | 62 | 11 | 28718761 |
| Pubmed | 3.17e-07 | 152 | 62 | 6 | 38360978 | ||
| Pubmed | 3.31e-07 | 80 | 62 | 5 | 35803934 | ||
| Pubmed | 4.50e-07 | 263 | 62 | 7 | 34702444 | ||
| Pubmed | 6.39e-07 | 407 | 62 | 8 | 12693553 | ||
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 8.54e-07 | 180 | 62 | 6 | 35198878 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 1.52e-06 | 457 | 62 | 8 | 32344865 | |
| Pubmed | 1.57e-06 | 317 | 62 | 7 | 30997501 | ||
| Pubmed | Mammalian miRNA RISC recruits CAF1 and PABP to affect PABP-dependent deadenylation. | 1.94e-06 | 14 | 62 | 3 | 19716330 | |
| Pubmed | 2.04e-06 | 209 | 62 | 6 | 36779422 | ||
| Pubmed | GW182 proteins directly recruit cytoplasmic deadenylase complexes to miRNA targets. | 2.42e-06 | 15 | 62 | 3 | 21981923 | |
| Pubmed | 2.49e-06 | 340 | 62 | 7 | 24332808 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 29791863 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 23040034 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 29434284 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 22539346 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 22363754 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 22888099 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 31300465 | ||
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 3.69e-06 | 361 | 62 | 7 | 26167880 | |
| Pubmed | Quantitative Proteomics Links the LRRC59 Interactome to mRNA Translation on the ER Membrane. | 4.73e-06 | 375 | 62 | 7 | 32788342 | |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | 4.92e-06 | 536 | 62 | 8 | 15840001 | |
| Pubmed | 5.06e-06 | 538 | 62 | 8 | 10512203 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | PCF11 SF3B1 CALD1 WDR33 MCM4 TRIM24 PRRC2A PICALM JMJD1C YTHDF2 | 6.80e-06 | 954 | 62 | 10 | 36373674 |
| Pubmed | 8.11e-06 | 22 | 62 | 3 | 22187428 | ||
| Pubmed | 8.48e-06 | 268 | 62 | 6 | 33640491 | ||
| Pubmed | 9.31e-06 | 23 | 62 | 3 | 28811219 | ||
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 26508027 | ||
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 31273197 | ||
| Pubmed | The clathrin assembly protein AP180 regulates the generation of amyloid-beta peptide. | 9.37e-06 | 3 | 62 | 2 | 19450545 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 1.42e-05 | 444 | 62 | 7 | 34795231 | |
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 23172285 | ||
| Pubmed | Mutations and karyotype predict treatment response in myelodysplastic syndromes. | 1.87e-05 | 4 | 62 | 2 | 30152885 | |
| Pubmed | Crystal structures of the Dab homology domains of mouse disabled 1 and 2. | 1.87e-05 | 4 | 62 | 2 | 12826668 | |
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 20181956 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 2.10e-05 | 861 | 62 | 9 | 36931259 | |
| Pubmed | 3.12e-05 | 5 | 62 | 2 | 20674675 | ||
| Pubmed | Ago-TNRC6 triggers microRNA-mediated decay by promoting two deadenylation steps. | 3.12e-05 | 5 | 62 | 2 | 19838187 | |
| Pubmed | 3.12e-05 | 5 | 62 | 2 | 18182036 | ||
| Pubmed | PCF11 C2CD3 SF3B1 CALD1 WDR33 SCG3 PCDHGA1 CAPRIN2 STOX1 PRRC2B MYBPC1 | 4.35e-05 | 1442 | 62 | 11 | 35575683 | |
| Pubmed | Proximity Mapping of CCP6 Reveals Its Association with Centrosome Organization and Cilium Assembly. | 4.35e-05 | 38 | 62 | 3 | 36674791 | |
| Pubmed | The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis. | 4.47e-05 | 218 | 62 | 5 | 33378226 | |
| Pubmed | Alzheimer's disease risk variants show association with cerebrospinal fluid amyloid beta. | 4.67e-05 | 6 | 62 | 2 | 18813964 | |
| Pubmed | Myo6 facilitates the translocation of endocytic vesicles from cell peripheries. | 4.67e-05 | 6 | 62 | 2 | 12857860 | |
| Pubmed | 5.02e-05 | 963 | 62 | 9 | 28671696 | ||
| Pubmed | 5.26e-05 | 371 | 62 | 6 | 15747579 | ||
| Pubmed | 5.46e-05 | 549 | 62 | 7 | 38280479 | ||
| Pubmed | 5.89e-05 | 42 | 62 | 3 | 34673265 | ||
| Pubmed | Mechanistic insights into COVID-19 by global analysis of the SARS-CoV-2 3CLpro substrate degradome. | 6.33e-05 | 43 | 62 | 3 | 34672947 | |
| Pubmed | 6.53e-05 | 7 | 62 | 2 | 18353773 | ||
| Pubmed | 6.53e-05 | 7 | 62 | 2 | 1694218 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 6.80e-05 | 774 | 62 | 8 | 15302935 | |
| Pubmed | 7.33e-05 | 242 | 62 | 5 | 34011540 | ||
| Pubmed | 8.69e-05 | 8 | 62 | 2 | 24768540 | ||
| Pubmed | The mutational landscape of lethal castration-resistant prostate cancer. | 8.69e-05 | 8 | 62 | 2 | 22722839 | |
| Pubmed | Disabled-2 colocalizes with the LDLR in clathrin-coated pits and interacts with AP-2. | 1.12e-04 | 9 | 62 | 2 | 11247302 | |
| Pubmed | 1.31e-04 | 274 | 62 | 5 | 34244482 | ||
| Pubmed | Transient Fcho1/2⋅Eps15/R⋅AP-2 Nanoclusters Prime the AP-2 Clathrin Adaptor for Cargo Binding. | 1.39e-04 | 10 | 62 | 2 | 27237791 | |
| Pubmed | Central role for PICALM in amyloid-β blood-brain barrier transcytosis and clearance. | 1.39e-04 | 10 | 62 | 2 | 26005850 | |
| Pubmed | 1.39e-04 | 10 | 62 | 2 | 21984185 | ||
| Pubmed | 1.44e-04 | 446 | 62 | 6 | 24255178 | ||
| Pubmed | 1.54e-04 | 1116 | 62 | 9 | 31753913 | ||
| Pubmed | Human GW182 Paralogs Are the Central Organizers for RNA-Mediated Control of Transcription. | 1.63e-04 | 59 | 62 | 3 | 28813667 | |
| Pubmed | 1.70e-04 | 11 | 62 | 2 | 21984184 | ||
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | 1.74e-04 | 462 | 62 | 6 | 31138677 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | 1.99e-04 | 1155 | 62 | 9 | 20360068 | |
| Pubmed | TRIM28 protects TRIM24 from SPOP-mediated degradation and promotes prostate cancer progression. | 2.04e-04 | 12 | 62 | 2 | 30479348 | |
| Pubmed | ARMC5 is part of an RPB1-specific ubiquitin ligase implicated in adrenal hyperplasia. | 2.25e-04 | 166 | 62 | 4 | 35687106 | |
| Pubmed | 2.29e-04 | 486 | 62 | 6 | 20936779 | ||
| Pubmed | Genetic influences on blood pressure within the Stanislas Cohort. | 2.41e-04 | 13 | 62 | 2 | 15076187 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 2.46e-04 | 934 | 62 | 8 | 33916271 | |
| Pubmed | 2.60e-04 | 69 | 62 | 3 | 32238831 | ||
| Pubmed | Multiplexed molecular interactions of nuclear receptors using fluorescent microspheres. | 2.81e-04 | 14 | 62 | 2 | 11500849 | |
| Pubmed | 3.19e-04 | 332 | 62 | 5 | 37433992 | ||
| Pubmed | 3.23e-04 | 733 | 62 | 7 | 34672954 | ||
| Pubmed | 3.23e-04 | 15 | 62 | 2 | 11341749 | ||
| Pubmed | 4.07e-04 | 1007 | 62 | 8 | 34597346 | ||
| Pubmed | 4.48e-04 | 83 | 62 | 3 | 28794006 | ||
| Pubmed | 4.58e-04 | 777 | 62 | 7 | 35844135 | ||
| Pubmed | Mapping HSA 3 loci in cattle: additional support for the ancestral synteny of HSA 3 and 21. | 4.70e-04 | 18 | 62 | 2 | 1783381 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 5.29e-04 | 208 | 62 | 4 | 33230847 | |
| Pubmed | 5.33e-04 | 1049 | 62 | 8 | 27880917 | ||
| Pubmed | 5.77e-04 | 808 | 62 | 7 | 20412781 | ||
| Pubmed | Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy. | 5.82e-04 | 20 | 62 | 2 | 29785026 | |
| Pubmed | 6.42e-04 | 21 | 62 | 2 | 6457647 | ||
| Pubmed | EEF1D Promotes Glioma Proliferation, Migration, and Invasion through EMT and PI3K/Akt Pathway. | 6.42e-04 | 21 | 62 | 2 | 33029523 | |
| Pubmed | 6.92e-04 | 1371 | 62 | 9 | 36244648 | ||
| Pubmed | 7.06e-04 | 22 | 62 | 2 | 12871600 | ||
| Pubmed | 7.06e-04 | 22 | 62 | 2 | 38507412 | ||
| Pubmed | The RNA-binding protein Snd1/Tudor-SN regulates hypoxia-responsive gene expression. | 7.06e-04 | 97 | 62 | 3 | 37151849 | |
| Pubmed | 7.09e-04 | 225 | 62 | 4 | 12168954 | ||
| Pubmed | Proteomic and yeast 2-hybrid screens to identify PTEN binding partners. | 7.21e-04 | 226 | 62 | 4 | 37839992 | |
| Interaction | CNOT9 interactions | PCF11 PLEKHG1 ANXA2R TNRC6A TNRC6B CEP152 TNRC6C PRRC2A JMJD1C YTHDF2 PRRC2B | 1.08e-10 | 231 | 62 | 11 | int:CNOT9 |
| Interaction | CNOT7 interactions | 1.09e-08 | 140 | 62 | 8 | int:CNOT7 | |
| Interaction | TNRC6A interactions | PCF11 TNRC6A TNRC6B CEP152 TNRC6C TRIM24 PRRC2A PICALM YTHDF2 PRRC2B | 1.30e-08 | 280 | 62 | 10 | int:TNRC6A |
| Interaction | CNOT6L interactions | 1.42e-08 | 93 | 62 | 7 | int:CNOT6L | |
| Interaction | GARRE1 interactions | 4.34e-08 | 167 | 62 | 8 | int:GARRE1 | |
| Interaction | SMG7 interactions | PCF11 TNRC6A TNRC6B CEP152 TNRC6C TRIM24 PRRC2A JMJD1C YTHDF2 PRRC2B | 4.45e-08 | 319 | 62 | 10 | int:SMG7 |
| Interaction | PAN3 interactions | 4.74e-08 | 65 | 62 | 6 | int:PAN3 | |
| Interaction | CNOT2 interactions | 7.12e-08 | 178 | 62 | 8 | int:CNOT2 | |
| Interaction | ZFP36 interactions | 8.11e-08 | 181 | 62 | 8 | int:ZFP36 | |
| Interaction | ALG13 interactions | 8.82e-08 | 183 | 62 | 8 | int:ALG13 | |
| Interaction | SYNE3 interactions | PLEKHG1 C2CD3 EXPH5 TNRC6A TNRC6B CEP152 TNRC6C APP POGLUT2 PICALM PRRC2B | 9.70e-08 | 444 | 62 | 11 | int:SYNE3 |
| Interaction | SMG5 interactions | 2.23e-07 | 84 | 62 | 6 | int:SMG5 | |
| Interaction | CNOT3 interactions | 2.27e-07 | 207 | 62 | 8 | int:CNOT3 | |
| Interaction | CELF1 interactions | 2.29e-07 | 288 | 62 | 9 | int:CELF1 | |
| Interaction | CPEB1 interactions | 3.20e-07 | 146 | 62 | 7 | int:CPEB1 | |
| Interaction | CNOT1 interactions | ANXA2R TNRC6A TNRC6B CEP152 TNRC6C TRIM24 PRRC2A YTHDF2 PRRC2B | 3.72e-07 | 305 | 62 | 9 | int:CNOT1 |
| Interaction | UNK interactions | SLC4A7 SF3B1 TNRC6A TNRC6B ZFYVE19 TNRC6C PRRC2A PICALM YTHDF2 PRRC2B | 4.36e-07 | 408 | 62 | 10 | int:UNK |
| Interaction | CEP85 interactions | 8.59e-07 | 169 | 62 | 7 | int:CEP85 | |
| Interaction | HELZ interactions | 1.17e-06 | 257 | 62 | 8 | int:HELZ | |
| Interaction | AGO1 interactions | 1.46e-06 | 183 | 62 | 7 | int:AGO1 | |
| Interaction | SMAP2 interactions | 1.82e-06 | 189 | 62 | 7 | int:SMAP2 | |
| Interaction | TNRC6B interactions | 2.34e-06 | 282 | 62 | 8 | int:TNRC6B | |
| Interaction | FAM184A interactions | 2.79e-06 | 72 | 62 | 5 | int:FAM184A | |
| Interaction | R3HDM2 interactions | 2.80e-06 | 129 | 62 | 6 | int:R3HDM2 | |
| Interaction | TNRC6C interactions | 4.15e-06 | 138 | 62 | 6 | int:TNRC6C | |
| Interaction | CNOT10 interactions | 4.70e-06 | 141 | 62 | 6 | int:CNOT10 | |
| Interaction | ANKRD17 interactions | 5.92e-06 | 226 | 62 | 7 | int:ANKRD17 | |
| Interaction | AGO3 interactions | 7.51e-06 | 153 | 62 | 6 | int:AGO3 | |
| Interaction | LATS1 interactions | 7.56e-06 | 440 | 62 | 9 | int:LATS1 | |
| Interaction | CPEB4 interactions | 8.40e-06 | 156 | 62 | 6 | int:CPEB4 | |
| Interaction | ODF2 interactions | 9.03e-06 | 158 | 62 | 6 | int:ODF2 | |
| Interaction | EIF4E2 interactions | 1.03e-05 | 246 | 62 | 7 | int:EIF4E2 | |
| Interaction | PRRC2B interactions | 1.67e-05 | 265 | 62 | 7 | int:PRRC2B | |
| Interaction | RNF214 interactions | 1.70e-05 | 104 | 62 | 5 | int:RNF214 | |
| Interaction | CEP135 interactions | 1.97e-05 | 272 | 62 | 7 | int:CEP135 | |
| Interaction | ANKHD1-EIF4EBP3 interactions | 2.04e-05 | 108 | 62 | 5 | int:ANKHD1-EIF4EBP3 | |
| Interaction | CNOT11 interactions | 2.44e-05 | 112 | 62 | 5 | int:CNOT11 | |
| Interaction | STIL interactions | 2.57e-05 | 190 | 62 | 6 | int:STIL | |
| Interaction | CNOT6 interactions | 2.65e-05 | 56 | 62 | 4 | int:CNOT6 | |
| Interaction | FAM120C interactions | 2.65e-05 | 191 | 62 | 6 | int:FAM120C | |
| Interaction | CEP192 interactions | 2.73e-05 | 192 | 62 | 6 | int:CEP192 | |
| Interaction | PUM1 interactions | 2.78e-05 | 287 | 62 | 7 | int:PUM1 | |
| Interaction | CFHR2 interactions | 2.79e-05 | 3 | 62 | 2 | int:CFHR2 | |
| Interaction | AGO4 interactions | 3.13e-05 | 118 | 62 | 5 | int:AGO4 | |
| Interaction | FUBP3 interactions | 3.46e-05 | 297 | 62 | 7 | int:FUBP3 | |
| Interaction | UBAP2L interactions | 3.53e-05 | 298 | 62 | 7 | int:UBAP2L | |
| Interaction | AP2A1 interactions | 3.61e-05 | 299 | 62 | 7 | int:AP2A1 | |
| Interaction | SAMD4B interactions | 3.68e-05 | 122 | 62 | 5 | int:SAMD4B | |
| Interaction | NUP35 interactions | 4.50e-05 | 424 | 62 | 8 | int:NUP35 | |
| Interaction | SEC16A interactions | 4.65e-05 | 426 | 62 | 8 | int:SEC16A | |
| Interaction | RNF43 interactions | 4.73e-05 | 427 | 62 | 8 | int:RNF43 | |
| Interaction | YTHDF2 interactions | 4.73e-05 | 312 | 62 | 7 | int:YTHDF2 | |
| Interaction | CNOT4 interactions | 4.78e-05 | 65 | 62 | 4 | int:CNOT4 | |
| Interaction | ZC3H7A interactions | 5.14e-05 | 215 | 62 | 6 | int:ZC3H7A | |
| Interaction | MEX3B interactions | 6.14e-05 | 222 | 62 | 6 | int:MEX3B | |
| Interaction | KIZ interactions | 7.69e-05 | 27 | 62 | 3 | int:KIZ | |
| Interaction | NINL interactions | 7.72e-05 | 458 | 62 | 8 | int:NINL | |
| Interaction | CNOT8 interactions | 7.95e-05 | 74 | 62 | 4 | int:CNOT8 | |
| Interaction | PUM2 interactions | 8.10e-05 | 144 | 62 | 5 | int:PUM2 | |
| Interaction | DAZL interactions | 8.37e-05 | 145 | 62 | 5 | int:DAZL | |
| Interaction | GSK3A interactions | 8.45e-05 | 464 | 62 | 8 | int:GSK3A | |
| Interaction | CTIF interactions | 9.29e-05 | 77 | 62 | 4 | int:CTIF | |
| Interaction | EYA4 interactions | 1.01e-04 | 243 | 62 | 6 | int:EYA4 | |
| Interaction | YTHDF3 interactions | 1.08e-04 | 246 | 62 | 6 | int:YTHDF3 | |
| Interaction | NIN interactions | 1.14e-04 | 359 | 62 | 7 | int:NIN | |
| Interaction | BICD1 interactions | 1.18e-04 | 250 | 62 | 6 | int:BICD1 | |
| Interaction | SOX7 interactions | 1.19e-04 | 82 | 62 | 4 | int:SOX7 | |
| Interaction | AP2B1 interactions | 1.44e-04 | 373 | 62 | 7 | int:AP2B1 | |
| Interaction | SPATA2 interactions | 1.49e-04 | 87 | 62 | 4 | int:SPATA2 | |
| Interaction | DCP1A interactions | 1.58e-04 | 166 | 62 | 5 | int:DCP1A | |
| Interaction | MIF interactions | 1.59e-04 | 264 | 62 | 6 | int:MIF | |
| Interaction | LZTS2 interactions | 1.67e-04 | 512 | 62 | 8 | int:LZTS2 | |
| Interaction | TNKS1BP1 interactions | 1.67e-04 | 168 | 62 | 5 | int:TNKS1BP1 | |
| Interaction | MKRN2 interactions | 1.75e-04 | 385 | 62 | 7 | int:MKRN2 | |
| Interaction | PRRC2A interactions | 1.87e-04 | 389 | 62 | 7 | int:PRRC2A | |
| Interaction | AR interactions | PCF11 ASXL1 SF3B1 WDR33 EXPH5 SVIL TRIM24 KDM6A HDAC7 JMJD1C PRRC2B | 1.97e-04 | 992 | 62 | 11 | int:AR |
| Interaction | MPHOSPH9 interactions | 2.10e-04 | 95 | 62 | 4 | int:MPHOSPH9 | |
| Interaction | SMC5 interactions | PCF11 SF3B1 CALD1 WDR33 MCM4 TRIM24 HDAC7 PRRC2A PICALM JMJD1C YTHDF2 | 2.11e-04 | 1000 | 62 | 11 | int:SMC5 |
| Interaction | PAN2 interactions | 2.11e-04 | 397 | 62 | 7 | int:PAN2 | |
| Interaction | GIGYF1 interactions | 2.13e-04 | 177 | 62 | 5 | int:GIGYF1 | |
| Interaction | PATL1 interactions | 2.13e-04 | 177 | 62 | 5 | int:PATL1 | |
| Interaction | TBK1 interactions | 2.28e-04 | 402 | 62 | 7 | int:TBK1 | |
| Interaction | RBFOX2 interactions | 2.36e-04 | 284 | 62 | 6 | int:RBFOX2 | |
| Interaction | GLI3 interactions | 2.36e-04 | 98 | 62 | 4 | int:GLI3 | |
| Interaction | QKI interactions | 2.96e-04 | 190 | 62 | 5 | int:QKI | |
| Interaction | KCNA3 interactions | CALD1 EXPH5 CAPRIN2 AKNAD1 TNRC6B COBL MCM4 PRRC2A JMJD1C YTHDF2 | 3.01e-04 | 871 | 62 | 10 | int:KCNA3 |
| Interaction | EIF4ENIF1 interactions | 3.16e-04 | 300 | 62 | 6 | int:EIF4ENIF1 | |
| Interaction | POMZP3 interactions | 3.31e-04 | 9 | 62 | 2 | int:POMZP3 | |
| Interaction | MYO18A interactions | 3.33e-04 | 303 | 62 | 6 | int:MYO18A | |
| Interaction | LIMA1 interactions | 3.38e-04 | 429 | 62 | 7 | int:LIMA1 | |
| Interaction | AMOT interactions | 3.89e-04 | 312 | 62 | 6 | int:AMOT | |
| Interaction | C10orf88 interactions | 4.07e-04 | 113 | 62 | 4 | int:C10orf88 | |
| Interaction | RBM47 interactions | 4.10e-04 | 204 | 62 | 5 | int:RBM47 | |
| Interaction | RBMS1 interactions | 4.38e-04 | 207 | 62 | 5 | int:RBMS1 | |
| Interaction | SEZ6L interactions | 5.03e-04 | 11 | 62 | 2 | int:SEZ6L | |
| Interaction | ZNF449 interactions | 5.03e-04 | 11 | 62 | 2 | int:ZNF449 | |
| Interaction | ZYX interactions | 5.15e-04 | 329 | 62 | 6 | int:ZYX | |
| Interaction | DTX2 interactions | 5.24e-04 | 330 | 62 | 6 | int:DTX2 | |
| Interaction | PXN interactions | 5.58e-04 | 334 | 62 | 6 | int:PXN | |
| Interaction | AGO2 interactions | 5.98e-04 | 472 | 62 | 7 | int:AGO2 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 1.62e-05 | 25 | 36 | 3 | 775 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 1.03e-03 | 24 | 36 | 2 | 485 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 5.74e-03 | 57 | 36 | 2 | 1179 | |
| Coexpression | GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_UP | 8.66e-06 | 200 | 63 | 6 | M8500 | |
| Coexpression | LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES | 2.00e-05 | 137 | 63 | 5 | M39241 | |
| ToppCell | 3'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.05e-07 | 179 | 63 | 6 | ec1d7017da325647b629de703135a404bbdc627d | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.19e-07 | 181 | 63 | 6 | e898ecb8d8f2eb2204225b7b0d665cadcd241139 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.57e-07 | 186 | 63 | 6 | 20340a5b5cc7f07386498a4ef937d6fbc9e347c4 | |
| ToppCell | Endothelial-B-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 4.65e-06 | 173 | 63 | 5 | a81992965137195d20fc498f750975303961a828 | |
| ToppCell | Control-Neuronal_cells-Neuronal_cells|Control / group, cell type (main and fine annotations) | 5.06e-06 | 176 | 63 | 5 | 98c07d26ba0dc0fe15ca0ea81f633d4591782bd1 | |
| ToppCell | Control-Neuronal_cells|Control / group, cell type (main and fine annotations) | 5.06e-06 | 176 | 63 | 5 | c29d09ecf0eb17f767d78af4b7f2e7725c967ff8 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-D|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.20e-06 | 177 | 63 | 5 | a0b172f40e0df97a288a5549ae7066697ad469b3 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-D-|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.20e-06 | 177 | 63 | 5 | ab8f09e118e4df696b0b4d33f013da020bdbd351 | |
| ToppCell | COVID-19-kidney-Stressed_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.50e-06 | 179 | 63 | 5 | 754f69bac7a1d5137f5141f6193285ccbfe361cb | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Lymphatic_EC|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.28e-06 | 184 | 63 | 5 | 15cbddea9efb2346a2028d77edfe9ba32923568f | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.28e-06 | 184 | 63 | 5 | 0087c605c161fd8a39aa394f51994a04e8353bf1 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_mature-Lymphatic_EC_mature_L.2.5.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.28e-06 | 184 | 63 | 5 | 968afa6b5ba84169377a24c150bb68749fa674d9 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_mature|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.28e-06 | 184 | 63 | 5 | 920f95625978132c2b6c76654ef6298244103e2d | |
| ToppCell | COPD-Endothelial-VE_Capillary_A|COPD / Disease state, Lineage and Cell class | 6.28e-06 | 184 | 63 | 5 | 5f4f7775d488ececf086c71441defecbee9d8a9c | |
| ToppCell | COVID-19-kidney-FLT1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.45e-06 | 185 | 63 | 5 | 673308ca0514a4d3629d61fe91e9d8fb31b72166 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell-Neuroendocrine|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.62e-06 | 186 | 63 | 5 | 2fab7abed16a894afdd0207e86fc43a25a77fb9e | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.62e-06 | 186 | 63 | 5 | ea2c8e0df038a00062d2098b4a9ac85141b9a728 | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.62e-06 | 186 | 63 | 5 | 9579180db2a0bf3f043b4d169f9a08cdc45b459a | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell-Neuroendocrine-Neuroendocrine_L.0.7.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.62e-06 | 186 | 63 | 5 | 714765585a644bf9817ab6eb3001b43b3c2d2410 | |
| ToppCell | ASK428-Endothelial-Lymphatic|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.97e-06 | 188 | 63 | 5 | c371bc340966cfe9205cbf4b62c6452f49f2559f | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.97e-06 | 188 | 63 | 5 | aeecbc057dc823f8fcea8a98f18d213bacc7f4db | |
| ToppCell | normal_Lung-Endothelial_cells-Lymphatic_ECs|normal_Lung / Location, Cell class and cell subclass | 7.34e-06 | 190 | 63 | 5 | 2185db6007404a2b22325f91460dd17635be9bba | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel|Adult / Lineage, Cell type, age group and donor | 7.34e-06 | 190 | 63 | 5 | 91bf3b7e9148589757436a53a4f58e0ebfe54400 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.53e-06 | 191 | 63 | 5 | 1924af7d8b0a0b892e480a9fd6d874941b0c0b5d | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.53e-06 | 191 | 63 | 5 | 88f91e57a1409bdeb91e9bf47510a6fb998a1bf5 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.72e-06 | 192 | 63 | 5 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | LAM-Endothelial-LymEndo|LAM / Condition, Lineage and Cell class | 7.92e-06 | 193 | 63 | 5 | 68eadc91c2d89edd2412e86dfe134dd7c0ef6ee9 | |
| ToppCell | COPD-Endothelial-Lymphatic|COPD / Disease state, Lineage and Cell class | 7.92e-06 | 193 | 63 | 5 | 18bcf08068a236c4575c7a07181ac893dfdcbeeb | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.92e-06 | 193 | 63 | 5 | 9ba688b35a9ead5d04691b3f3f15484f02dbbd0d | |
| ToppCell | COPD-Endothelial|COPD / Disease state, Lineage and Cell class | 7.92e-06 | 193 | 63 | 5 | 093b28dcccb5841c995d0b33fae0efd6b88f97e0 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.92e-06 | 193 | 63 | 5 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.92e-06 | 193 | 63 | 5 | 0f2967afbbf4e538b63f985c0acc2e5d9aab7589 | |
| ToppCell | COVID-19-kidney-FLT1+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 7.92e-06 | 193 | 63 | 5 | 479abb1cd2eb978b8a4fdb900069a6329fc8cade | |
| ToppCell | nucseq-Endothelial-Endothelial_Lymphatic-LEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.12e-06 | 194 | 63 | 5 | f772a9f9ef8635aeaeb8b022dbb94e9672b36ead | |
| ToppCell | nucseq-Endothelial-Endothelial_Lymphatic-LEC-LEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.12e-06 | 194 | 63 | 5 | 3b73f2d305a7566f7ab567e5f18c82cd3d80e32c | |
| ToppCell | IPF-Endothelial|IPF / Disease state, Lineage and Cell class | 8.12e-06 | 194 | 63 | 5 | 9591993aa2dcba3d09a0f1ea8b8f2439c26482d6 | |
| ToppCell | nucseq-Endothelial-Endothelial_Lymphatic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.12e-06 | 194 | 63 | 5 | 5d2b3ed5374e2ab10c1c7eb3a03139fc95036a48 | |
| ToppCell | Control-Endothelial|Control / Disease state, Lineage and Cell class | 8.12e-06 | 194 | 63 | 5 | 485fe5538fabec457b9a51feb641f2a91cbf4e18 | |
| ToppCell | Children_(3_yrs)-Endothelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.33e-06 | 195 | 63 | 5 | 094cf6591daa5ffad36e44122b6f524a3a34c2fd | |
| ToppCell | Endothelial|World / Lineage, Cell type, age group and donor | 8.54e-06 | 196 | 63 | 5 | 96c6d78482a130ce4e29f6629972a06d10d7530e | |
| ToppCell | proximal-Endothelial-Lymphatic|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.75e-06 | 197 | 63 | 5 | 8835961bd734a86063fd854cd2fb7028aefb7a72 | |
| ToppCell | Parenchyma_Control_(B.)-Endothelial-TX-Endothelial-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 8.75e-06 | 197 | 63 | 5 | f969685dee212f33a6f09e54c0cd1fd24ffef546 | |
| ToppCell | proximal-Endothelial-Lymphatic-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.75e-06 | 197 | 63 | 5 | 8d79e747e344656e2bfc7fe872b4430dca941196 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.75e-06 | 197 | 63 | 5 | b0036cf3f7e6edf8e43f16cd2f0f0e80471d2576 | |
| ToppCell | nucseq-Endothelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.75e-06 | 197 | 63 | 5 | ebf9be068eaa658493fa7884fd19f34642922acb | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Endothelial-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.75e-06 | 197 | 63 | 5 | 1a137af40697137bb9d2b5caf2b1ffda55f04461 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.75e-06 | 197 | 63 | 5 | 3a0e97bfebe82f9687d518baaad7f20d0ffea8a1 | |
| ToppCell | 356C-Endothelial_cells|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.75e-06 | 197 | 63 | 5 | f20eda534b2b28986790b28ce150ca3ba067593a | |
| ToppCell | proximal-3-Endothelial-Lymphatic|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.75e-06 | 197 | 63 | 5 | 1c64e4eb9bfbaf5d6b4349642858f83a00d4d4c6 | |
| ToppCell | 390C-Endothelial_cells|390C / Donor, Lineage, Cell class and subclass (all cells) | 8.75e-06 | 197 | 63 | 5 | aa381acea0f7882d39435a6f713386bf0588b5f8 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Endothelial-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.75e-06 | 197 | 63 | 5 | 96d63a8d00583e2aa0a38412e2ae27e23f399493 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.97e-06 | 198 | 63 | 5 | 9ab0db78394e730f6866b2db80047149024ad5f6 | |
| ToppCell | distal-1-Endothelial-Bronchial_Vessel_1|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.97e-06 | 198 | 63 | 5 | 5cd81fe1a21c0e1a7f0d5a62ddf8e422b05aedc7 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.97e-06 | 198 | 63 | 5 | b3a020522e064bb61949d38e442f24026e339364 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.97e-06 | 198 | 63 | 5 | fc4b7c3ad52bc5c8b40fa04a156bfbb58afa2872 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.97e-06 | 198 | 63 | 5 | e47d0e2c6353315c85d7007742bb16b0f05795ed | |
| ToppCell | Parenchymal-NucSeq-Endothelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.19e-06 | 199 | 63 | 5 | a4a9a1c2a34b5a8318a55d1211d6c8661ca9793e | |
| ToppCell | Biopsy_Other_PF-Endothelial|Biopsy_Other_PF / Sample group, Lineage and Cell type | 9.41e-06 | 200 | 63 | 5 | f9916134486fb1dac55f5e7e8deb35e7a3b85770 | |
| ToppCell | Parenchymal-10x5prime-Endothelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.41e-06 | 200 | 63 | 5 | 0e648e9eb96c83a94505d07323785a7a40997eb0 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Lymphatic-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.41e-06 | 200 | 63 | 5 | f99d0d3f51b4893fa7898c5b435494358a654cbd | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Lymphatic|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.41e-06 | 200 | 63 | 5 | e65d4ae3d48f68c12edd5dc2c2f4e25e4acfadf1 | |
| ToppCell | Parenchyma_Control_(B.)-Endothelial-TX-Lymphatic|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 9.41e-06 | 200 | 63 | 5 | 4ec8e30dd241d83a1bba1c5967b6a4656afbfafd | |
| ToppCell | Biopsy_Other_PF-Endothelial-Endothelial_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type | 9.41e-06 | 200 | 63 | 5 | 40d57a383c79d3365e033d08efd9371f0bc5bf55 | |
| ToppCell | distal-2-Endothelial-Capillary_Intermediate_1|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.41e-06 | 200 | 63 | 5 | 7a99f28670ffb8ece7873d8a9bcd2a3936d0255d | |
| ToppCell | Bronchial-10x5prime-Endothelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.41e-06 | 200 | 63 | 5 | ad34c978cc6b89b4c1c8c9b2fb2a938051b555a0 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-like|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.91e-05 | 134 | 63 | 4 | 64979e1a056b7406e1be39c5ebe2f8d731ac3c17 | |
| ToppCell | Control-Endothelial_cells-Inflamed_endothelial_cells|Control / group, cell type (main and fine annotations) | 7.79e-05 | 160 | 63 | 4 | 958256e3d3836160763b82bb48f794087918d935 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-D_cells_(SST+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.18e-05 | 162 | 63 | 4 | f2a87019ff9b466617e90c60d182ab7d14581cc9 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_bronchial_vessel|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.37e-05 | 163 | 63 | 4 | 977a970b1296234c22178420294cea73506ee02f | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_bronchial_vessel-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.37e-05 | 163 | 63 | 4 | ba7d02db0f0e2f9916ec8db52c067c87b6917c23 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.41e-05 | 168 | 63 | 4 | 435ef2e4d702e978d54f9d1f5a047f39c691cc63 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.63e-05 | 169 | 63 | 4 | 987ff79ad563825dd9877ea8ccb536758f8c6700 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 9.85e-05 | 170 | 63 | 4 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | COVID_vent-Lymphocytic-Dendritic-pDC|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.01e-04 | 171 | 63 | 4 | 779c951d274ecbd1d546ac425d6c8e718623be5a | |
| ToppCell | COVID_vent-Lymphocytic-Dendritic|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.01e-04 | 171 | 63 | 4 | debbb071d260639b16269c94d172766908325c58 | |
| ToppCell | nucseq-Epithelial-Epithelial_Neuro-Secretory-PNEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.01e-04 | 171 | 63 | 4 | f4321133190a3df9d31f5d4021a464d3840145f1 | |
| ToppCell | nucseq-Epithelial-Epithelial_Neuro-Secretory-PNEC-PNEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.01e-04 | 171 | 63 | 4 | ed4fb6c84579d99df33de5f8f928c3cd2f3d3d72 | |
| ToppCell | Endothelial-B-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 1.03e-04 | 172 | 63 | 4 | d4e98ff9c7cbc95457e1d71fa60f151a2f178dae | |
| ToppCell | nucseq-Epithelial-Epithelial_Neuro-Secretory|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.03e-04 | 172 | 63 | 4 | d0cdedd734406988a9a93d7300c7b1a8b4b45c38 | |
| ToppCell | Bronchial_Biopsy-Endothelial-Lymphatic|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.03e-04 | 172 | 63 | 4 | c41f5a66781bbf63afce7ca5d118cc6d8e0fe0bc | |
| ToppCell | Endothelial-B-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 1.03e-04 | 172 | 63 | 4 | 8a527dff06d841a86c7eb04a1dd9630787294da4 | |
| ToppCell | Control-Endothelial_cells-Systemic_venous_endothelial_cells|Control / group, cell type (main and fine annotations) | 1.03e-04 | 172 | 63 | 4 | c55dce1ed3ed7312394b4e050e1de852a994e130 | |
| ToppCell | PND01-03-samps-Endothelial-Postnatal_endothelial-endothelial_cells_D|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.08e-04 | 174 | 63 | 4 | b4f3f5334803e5903bc496decf923f2e44f7fa3c | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.08e-04 | 174 | 63 | 4 | 9cc7251661ea2b1565eef1dfb8cf6dec3ade13d4 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_vein-D231|Adult / Lineage, Cell type, age group and donor | 1.08e-04 | 174 | 63 | 4 | 2dd647c4fdf99fd1f7b838efef01baf2cbc3446d | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)|Adult / Lineage, Cell type, age group and donor | 1.10e-04 | 175 | 63 | 4 | 4db1a3c284488b3f6de7568363f176d74e2a4587 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)-D231|Adult / Lineage, Cell type, age group and donor | 1.10e-04 | 175 | 63 | 4 | 8d9f44a2633b71fb4d2b4a7d9530f954e07c4a18 | |
| ToppCell | 3'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.13e-04 | 176 | 63 | 4 | 5d3b2395bb842eea39175f5af6a4c76527e2fc31 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_vein|Adult / Lineage, Cell type, age group and donor | 1.13e-04 | 176 | 63 | 4 | 043683c61c5d1a7f8a4666a612310246bd3d83a2 | |
| ToppCell | metastatic_Brain-B_lymphocytes-GrB-secreting_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 1.15e-04 | 177 | 63 | 4 | 43e1d0d3cf8f0c02e67d91f8dd1761df23d59e07 | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.15e-04 | 177 | 63 | 4 | b1775e05c28883a15c56628028770bc59d3233fb | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.18e-04 | 178 | 63 | 4 | 4b3ea0921bc598ebb9f63780ecdf8ad4349f3666 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D231|Adult / Lineage, Cell type, age group and donor | 1.18e-04 | 178 | 63 | 4 | c80ca7a2d3f976089a5e71d0cd9ba9a1c0bd2815 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.18e-04 | 178 | 63 | 4 | ad3de3e03a401dac64431a541899445262246347 | |
| ToppCell | COVID-19_Convalescent-PLT_1|World / Disease Group and Platelet Clusters | 1.20e-04 | 179 | 63 | 4 | d0f2764c6fc5d61fd69e9231b3603a80ac373f65 | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.20e-04 | 179 | 63 | 4 | 40c65e8623547aeb80f9cd2366e29072467ce069 | |
| ToppCell | COPD-Epithelial-PNEC|Epithelial / Disease state, Lineage and Cell class | 1.20e-04 | 179 | 63 | 4 | 988d0853c391da1e5004f73f3678047418d3f6d3 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 179 | 63 | 4 | 4135f9e8cd8494cbc189e5210dded84659643fb8 | |
| ToppCell | COVID-19-kidney-PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.23e-04 | 180 | 63 | 4 | 493cf8d1a8f2a1ed2672f394a0338b110fd81d88 | |
| ToppCell | Control-Endothelial_cells-Capillary_endothelial_cells|Control / group, cell type (main and fine annotations) | 1.23e-04 | 180 | 63 | 4 | b043f9ffb9a4cd427a15bebb86a711c7b08866e8 | |
| Drug | Aztreonam [78110-38-0]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 1.60e-05 | 197 | 62 | 6 | 2282_DN | |
| Drug | (cis-) Nanophine [5072-45-7]; Down 200; 26.8uM; MCF7; HT_HG-U133A | 1.60e-05 | 197 | 62 | 6 | 4363_DN | |
| Drug | Nomifensine maleate [32795-47-4]; Down 200; 11.2uM; PC3; HT_HG-U133A | 1.64e-05 | 198 | 62 | 6 | 2062_DN | |
| Drug | Guanabenz acetate [23256-50-0]; Down 200; 13.8uM; HL60; HG-U133A | 1.69e-05 | 199 | 62 | 6 | 2045_DN | |
| Disease | MYELODYSPLASTIC SYNDROME | 4.19e-05 | 5 | 61 | 2 | 614286 | |
| Disease | Myelodysplastic syndrome | 4.19e-05 | 5 | 61 | 2 | cv:C3463824 | |
| Disease | Mental deterioration | 1.50e-04 | 9 | 61 | 2 | C0234985 | |
| Disease | Mild cognitive disorder | 1.50e-04 | 9 | 61 | 2 | C1270972 | |
| Disease | Uterine leiomyoma, estrogen-receptor negative breast cancer | 1.87e-04 | 10 | 61 | 2 | EFO_1000650, HP_0000131 | |
| Disease | Impaired cognition | 3.76e-04 | 14 | 61 | 2 | C0338656 | |
| Disease | myelodysplastic syndrome (implicated_via_orthology) | 4.34e-04 | 15 | 61 | 2 | DOID:0050908 (implicated_via_orthology) | |
| Disease | cortical thickness | PLEKHG1 ZNF469 SF3B1 TNRC6A TNRC6B STOX1 CAMTA1 LINC02915 JMJD1C | 4.45e-04 | 1113 | 61 | 9 | EFO_0004840 |
| Disease | interferon gamma measurement, platelet-derived growth factor BB measurement, interleukin 4 measurement, interleukin 10 measurement, stromal cell-derived factor 1 alpha measurement, interleukin-6 measurement, interleukin 12 measurement, interleukin 17 measurement, vascular endothelial growth factor measurement, fibroblast growth factor basic measurement, granulocyte colony-stimulating factor measurement | 4.95e-04 | 16 | 61 | 2 | EFO_0004750, EFO_0004753, EFO_0004762, EFO_0004810, EFO_0008130, EFO_0008142, EFO_0008165, EFO_0008174, EFO_0008184, EFO_0008264, EFO_0008293 | |
| Disease | body fat percentage | 5.10e-04 | 488 | 61 | 6 | EFO_0007800 | |
| Disease | Amnesia | 5.60e-04 | 17 | 61 | 2 | C0002622 | |
| Disease | Tactile Amnesia | 5.60e-04 | 17 | 61 | 2 | C0750906 | |
| Disease | Amnestic State | 5.60e-04 | 17 | 61 | 2 | C0750907 | |
| Disease | Dissociative Amnesia | 5.60e-04 | 17 | 61 | 2 | C0236795 | |
| Disease | Global Amnesia | 5.60e-04 | 17 | 61 | 2 | C0262497 | |
| Disease | Hysterical amnesia | 5.60e-04 | 17 | 61 | 2 | C0233750 | |
| Disease | Alzheimer disease, psychotic symptoms | 5.60e-04 | 17 | 61 | 2 | EFO_0005940, MONDO_0004975 | |
| Disease | Temporary Amnesia | 5.60e-04 | 17 | 61 | 2 | C0233796 | |
| Disease | acute myeloid leukemia (is_implicated_in) | 7.11e-04 | 84 | 61 | 3 | DOID:9119 (is_implicated_in) | |
| Disease | prothrombin time measurement | 8.61e-04 | 21 | 61 | 2 | EFO_0008390 | |
| Disease | platelet component distribution width | 9.18e-04 | 755 | 61 | 7 | EFO_0007984 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 9.39e-04 | 364 | 61 | 5 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | Acute Confusional Senile Dementia | 1.14e-03 | 99 | 61 | 3 | C0546126 | |
| Disease | Alzheimer's Disease, Focal Onset | 1.14e-03 | 99 | 61 | 3 | C0750900 | |
| Disease | Alzheimer Disease, Early Onset | 1.14e-03 | 99 | 61 | 3 | C0750901 | |
| Disease | Presenile dementia | 1.14e-03 | 99 | 61 | 3 | C0011265 | |
| Disease | Alzheimer Disease, Late Onset | 1.14e-03 | 99 | 61 | 3 | C0494463 | |
| Disease | mean platelet volume | 1.15e-03 | 1020 | 61 | 8 | EFO_0004584 | |
| Disease | Familial Alzheimer Disease (FAD) | 1.18e-03 | 100 | 61 | 3 | C0276496 | |
| Disease | Alzheimer's Disease | 1.21e-03 | 101 | 61 | 3 | C0002395 | |
| Disease | pre-eclampsia (is_implicated_in) | 1.22e-03 | 25 | 61 | 2 | DOID:10591 (is_implicated_in) | |
| Disease | mean reticulocyte volume | 1.27e-03 | 799 | 61 | 7 | EFO_0010701 | |
| Disease | inflammatory biomarker measurement | 1.32e-03 | 26 | 61 | 2 | EFO_0004872 | |
| Disease | neuroimaging measurement | 1.55e-03 | 1069 | 61 | 8 | EFO_0004346 | |
| Disease | Developmental Academic Disorder | 1.65e-03 | 29 | 61 | 2 | C1330966 | |
| Disease | Learning Disorders | 1.65e-03 | 29 | 61 | 2 | C0023186 | |
| Disease | Learning Disturbance | 1.65e-03 | 29 | 61 | 2 | C0751263 | |
| Disease | Adult Learning Disorders | 1.65e-03 | 29 | 61 | 2 | C0751262 | |
| Disease | Learning Disabilities | 1.65e-03 | 29 | 61 | 2 | C0751265 | |
| Disease | Hematopoetic Myelodysplasia | 1.65e-03 | 29 | 61 | 2 | C2713368 | |
| Disease | cortical surface area measurement | PLEKHG1 ZNF469 SF3B1 TNRC6A TNRC6B STOX1 PRRC2A PICALM LINC02915 | 1.69e-03 | 1345 | 61 | 9 | EFO_0010736 |
| Disease | myelodysplastic syndrome (is_implicated_in) | 1.76e-03 | 30 | 61 | 2 | DOID:0050908 (is_implicated_in) | |
| Disease | blood pressure, chronic obstructive pulmonary disease | 2.00e-03 | 32 | 61 | 2 | EFO_0000341, EFO_0004325 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EKPKNQLWPESSTSD | 601 | O94986 | |
| QASGSQPVGKWNSKD | 1311 | Q9Y6Y1 | |
| RDPAWQKPQQKSEGA | 691 | A6NC98 | |
| NVQNGKWDSDPSGTK | 46 | P05067 | |
| LDWNQAQKSGDPGPS | 386 | Q9UHX3 | |
| KNGATQGWDAPQEVP | 311 | Q9BZP6 | |
| QWSQKEKTGERPANP | 61 | P0C7M7 | |
| AKPTEFSWPGTQKQQ | 86 | Q3ZCQ2 | |
| GSSVDKDEKPNWNQS | 1026 | Q8IXJ9 | |
| SSANASKWSPPQNYK | 136 | Q96K21 | |
| WPKKAIQESNDTNKG | 36 | Q8TCD1 | |
| SEKPSVQSVKPWSDQ | 26 | A0A3B3IT52 | |
| KPQNTNKECSWGSPI | 116 | O75747 | |
| KQEAQAGPWPFSSSQ | 356 | P98082 | |
| AANPIESQWNPKKTT | 616 | P33991 | |
| LPVPSSSWEDGKGKQ | 1731 | Q6ZU64 | |
| KAGEETLKNSQPPWD | 421 | Q15652 | |
| DSNPNVSWGKKVQPI | 896 | Q9BZQ6 | |
| QPADENWDPTGTKKI | 1006 | O15550 | |
| PWNSKPPATQETKSE | 351 | O43679 | |
| DSKSKNQPSFQWRQP | 451 | Q01064 | |
| PKALGNQQPSWDSED | 101 | P07492 | |
| TQKPLTEEAKNWAPG | 86 | P16581 | |
| KSAWDQPSLPEGNKN | 1561 | Q8NEV8 | |
| KSGTEPKENVENWQS | 576 | O94913 | |
| GWSSPQTDQNKEPKS | 2191 | Q4AC94 | |
| GPQKSPLWEKNGSEN | 451 | O75128 | |
| NKNSWPKEQTPELTD | 156 | Q5T1N1 | |
| EQDSKQPETPKSWEN | 536 | Q6IMN6 | |
| PLSEEGWKQKPNLNA | 866 | Q8WUI4 | |
| LNGNWTEPPQCKDST | 191 | Q03591 | |
| NKAPANKDPSESWTL | 126 | O75363 | |
| PNDKKSELLPAGWNN | 46 | Q92530 | |
| KKEPFSQQAPPNTDW | 801 | Q9Y5H4 | |
| KAPDPAWSANATKGN | 156 | Q14D33 | |
| PSAKPSQWKREAVGN | 301 | Q2M3C7 | |
| NTKANPGTNWGETLK | 646 | Q9HCJ0 | |
| PPNPSNETLAQWKKD | 771 | Q9Y6M7 | |
| VSWKPQDSSEQPQEK | 1081 | O95425 | |
| AWGESTPLANKPGKQ | 981 | P12259 | |
| WKKQNPGADTSAPTG | 351 | Q15270 | |
| KDGTGWASKQEQSDP | 81 | P48634 | |
| INEWLTKTPDGNKSP | 746 | Q05682 | |
| AQKPQSPGWKNMSST | 121 | Q8N8G6 | |
| GTTKNDVNWSQPGEK | 556 | Q13492 | |
| NSSNGKSEWLDPSQK | 796 | O15164 | |
| KPSNTSEKEQGPEFW | 261 | P17040 | |
| TGGKNPDPWAKNLNE | 561 | P02787 | |
| TPKKLSSWDQAETPG | 211 | O75533 | |
| DTGKKPASWSQSPQN | 876 | Q6ZVD7 | |
| PKDGTGWANKQDQQD | 81 | Q5JSZ5 | |
| GWANKQDQQDPKSSS | 86 | Q5JSZ5 | |
| SWDKNGSPNKQPSSE | 901 | Q5JSZ5 | |
| TQDWALPEGPNQGAK | 3136 | Q86WI1 | |
| QANTGPPWESKNSTA | 291 | Q6UW63 | |
| KPASTENGQWKGQAP | 2426 | Q96JG9 | |
| PLKIQKDGWASPQES | 1051 | Q9ULL1 | |
| SGSKDSQQPIKFWDP | 261 | Q9C0J8 | |
| SQQPIKFWDPKTGQS | 266 | Q9C0J8 | |
| PWTTDAKIQNKNCPG | 66 | Q8N883 | |
| NQEFPTGKVPNSWSK | 171 | Q14590 | |
| DPNKPTSWTENQAGK | 211 | Q8WXD2 | |
| DSSKPVSSPDWNKQQ | 936 | Q8NDV7 | |
| GTWDNKGPVAKAPSQ | 276 | Q9Y5A9 | |
| EKTPSSWNENPSKDQ | 716 | Q9UPQ9 | |
| PGKWTKNGLPVQESD | 461 | Q00872 |